NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is 67076P902. A total of 1 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $17,000 | – | 4,800 | +1500.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 300 | -86.4% | 0.00% | – |
| Q1 2015 | $2,000 | +100.0% | 2,200 | -21.4% | 0.00% | – |
| Q4 2014 | $1,000 | -98.6% | 2,800 | -83.2% | 0.00% | -100.0% |
| Q3 2014 | $73,000 | -3.9% | 16,700 | +9.2% | 0.00% | 0.0% |
| Q2 2014 | $76,000 | +90.0% | 15,300 | +109.6% | 0.00% | 0.0% |
| Q1 2014 | $40,000 | +3900.0% | 7,300 | +3550.0% | 0.00% | – |
| Q4 2013 | $1,000 | -98.1% | 200 | -97.5% | 0.00% | -100.0% |
| Q3 2013 | $52,000 | +188.9% | 7,900 | +125.7% | 0.00% | – |
| Q2 2013 | $18,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 200 | $1,000 | 0.00% |